Comparison of minimally invasive surgery and open surgery following chemotherapy for cStage IVb gastric cancer: a multicenter retrospective cohort study - Summary - MDSpire

Evaluation of Minimally Invasive versus Open Surgical Approaches after Chemotherapy in Patients with Stage IVb Gastric Cancer: A Multicenter Retrospective Analysis

  • By

  • Yusuke Fujii

  • Shigeo Hisamori

  • Nobuaki Hoshino

  • Seiichiro Kanaya

  • Eiji Tanaka

  • Yoshito Yamashita

  • Akira Miki

  • Kosuke Toda

  • Michihiro Yamamoto

  • Yosuke Kinjo

  • Dai Manaka

  • Hiroaki Hata

  • Hironori Kawada

  • Shotaro Matsuda

  • Atsushi Itami

  • Kyoichi Hashimoto

  • Kenjiro Hirai

  • Sanae Nakajima

  • Hiroshi Okabe

  • Masazumi Sakaguchi

  • Yuichiro Kawamura

  • Takashi Sakamoto

  • Shintaro Okumura

  • Tatsuto Nishigori

  • Shigeru Tsunoda

  • Kazutaka Obama

  • July 20, 2026

Share

Objective:

To compare perioperative and survival outcomes between minimally invasive surgery (MIS) and open surgery in patients with stage IV gastric cancer who underwent curative-intent gastrectomy after systemic chemotherapy.

Approach:
  • Study Design: Multicenter retrospective cohort study conducted across 19 institutions, approved by the Ethics Committee of Kyoto University.
  • Patient Cohort: Included adults aged ≥ 18 years with cStage IVb gastric or gastroesophageal junction adenocarcinoma who underwent curative-intent surgery after chemotherapy from January 2011 to December 2022.
  • Surgical Indications: Determined by multidisciplinary consensus based on the achievability of R0 resection post-chemotherapy.
  • Outcomes: Primary outcome was postoperative complications (Clavien–Dindo grade ≥ II); secondary outcomes included 30-day mortality, operative time, blood loss, lymph node dissection, and survival metrics.
Key Findings:
  • The primary outcome was postoperative complications (Clavien–Dindo grade ≥ II); secondary outcomes included 30-day mortality, operative time, blood loss, lymph node dissection, and survival metrics.
Interpretation:

The comparative safety and oncologic adequacy of MIS versus open gastrectomy in stage IV gastric cancer remain unclear due to fragmented evidence.

Limitations:
  • Small, single-institutional cohorts in existing literature.
  • Variability in surgeon experience and surgical era not accounted for.
Conclusion:

The study aims to provide robust evidence on the outcomes of MIS versus open surgery in a multicenter setting.

Sources:

Original Source(s)

Related Content